Publications

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines.

SMITH, SG; Smits, K; Joosten, SA; Van Meijgaarden, KE; Satti, I; FLETCHER, HA; Caccamo, N; Dieli, F; Mascart, F; McShane, H; DOCKRELL, HM; Ottenhoff, TH M; TBVI TB Biomarker Working Group,;

2015

PloS one, (2015).10 9 10.1371/journal.pone.0138042.

Effective anti-tuberculosis therapy correlates with plasma small RNA.

Honeyborne, I; Lipman, MC; ECKOLD, C; Evangelopoulos, D; Gillespie, SH; Pym, A; McHugh, TD;

2015

The European respiratory journal, (2015).45 6 10.1183/09031936.00221214.

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.

HASSAN, SS; Akram, M; KING, EC; DOCKRELL, HM; CLIFF, JM;

2015

PloS one, (2015).10 9 10.1371/journal.pone.0137646.

Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area.

Guerra-Assunção, JA; CRAMPIN, AC; HOUBEN, RM G J; MZEMBE, T; Mallard, K; COLL, F; KHAN, P; Banda, L; Chiwaya, A; Pereira, RP A; MCNERNEY, R; FINE, PE M; Parkhill, J; CLARK, TG; GLYNN, JR;

2015

eLife, (2015).4 4 10.7554/eLife.05166.

HIV treatment cascade in tuberculosis patients.

LESSELLS, RJ; Swaminathan, S; GODFREY-FAUSSETT, P;

2015

Current opinion in HIV and AIDS, (2015).10 6 10.1097/COH.0000000000000197.

Multidrug resistant tuberculosis.

Millard, J; Ugarte-Gil, C; MOORE, DA J;

2015

BMJ (Clinical research ed), (2015).350 feb26 10.1136/bmj.h882.

Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment.

CLIFF, JM; Cho, J-E; LEE, J-S; Ronacher, K; KING, EC; Van Helden, P; Walzl, G; DOCKRELL, HM;